The bill would allow uninsured residents to purchase the devices at $60 or less for a two-pack. The bill would also cap the price at a $60 copay for the commercially insured.
The Colorado Association of Health Plans has not taken a position on the proposal, according to Colorado Public Radio.
Amanda Massey, the association’s executive director, told the station copay caps do not reduce the actual cost of any drug.
“Coloradans deserve access to affordable, life-saving medications and this bill only hides the outrageous prices set by Big Pharma and forces all Coloradans to pay for it through increased health insurance premiums,” Ms. Massey said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
